KUMUTHA DANIEL: Open Payments
NPI 1225627136 · LARGO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,862 in 85 payments from 17 companies in 2025. Trend: 2023 $305 · 2024 $748 · 2025 $1,862
Food & beverage: $1,751Education: $111
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 12 | $248 |
| Teva Pharmaceuticals USA, Inc. | 8 | $245 |
| Janssen Pharmaceuticals, Inc | 10 | $244 |
| Alkermes, Inc. | 11 | $199 |
| Vanda Pharmaceuticals Inc. | 9 | $189 |
| ABBVIE INC. | 8 | $145 |
| Otsuka America Pharmaceutical, Inc. | 6 | $139 |
| Neurocrine BioSciences, Inc. | 4 | $96 |
| Axsome Therapeutics, Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
Products named: INVEGA SUSTENNA, REXULTI, VRAYLAR, FANAPT, ABILIFY MAINTENA, ARISTADA, ABILIFY ASIMTUFII, INGREZZA.
Industry payments across MD — which companies pay providers there.
